Molecular determinants of STEC-HUS: from complement activation to microvascular thrombosis. [PDF]
Santarsiero D +14 more
europepmc +1 more source
Complement-targeted therapies for transplant-associated thrombotic microangiopathy: recent advances. [PDF]
Tokura T, Motomura S.
europepmc +1 more source
Charting the Course of Recurrent C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative GN in Kidney Transplant Recipients. [PDF]
Wong EKS.
europepmc +1 more source
First report of perioperative iptacopan interruption in paroxysmal nocturnal hemoglobinuria without breakthrough hemolysis. [PDF]
Tokuda K +7 more
europepmc +1 more source
Management of IgA nephropathy and the expanding role of immunomodulation. [PDF]
Canetta PA, Reich HN.
europepmc +1 more source
C3 glomerulopathy in transplant "like yet unlike native": Pathophysiology, recent advances in therapeutics and evolving paradigms. [PDF]
Chutani A, Norouzi S, Lerma EV.
europepmc +1 more source
Systems Pharmacology Approach to Paroxysmal Nocturnal Hemoglobinuria: Quantitative Framework for Biomarker Dynamics across Multi-Mechanistic Therapies. [PDF]
Cruikshank A +4 more
europepmc +1 more source
Iptacopan in Patients With IgA Nephropathy From East Asia. [PDF]
Zhang H +12 more
europepmc +1 more source
C3 Glomerulopathy Diagnosis, Current Treatments, and Emerging Therapies. [PDF]
Mashayekhi M +10 more
europepmc +1 more source
WCN24-555 PHARMACOKINETICS OF SINGLE DOSES OF IPTACOPAN
Robert Schmouder +3 more
doaj +1 more source

